Limitations, agreements, and source contact

Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT · Source last updated 2015-12-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

limitations And Caveats

description

None. Trial was completed.

point Of Contact

email

mark_kieran@dfci.harvard.edu

organization

Dana-Farber Cancer Institute

phone

(617) 632-4907

title

Mark Kieran

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice